荣昌生物(09995.HK)预计2026年中期归母净利润约47亿元

智通财经
Aug 05
【荣昌生物(09995.HK)预计2026年中期归母净利润约47亿元】智通财经APP讯,荣昌生物(09995.HK)发布公告,预计2026年中期营业收入约人民币58.5亿元,同比增加约433%。预计2026年中期归属于母公司所有者的净利润约人民币47亿元,与上年同期相比,实现扭亏为盈。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10